EUVIMEDEUVIMED entdecken
Crossref

Acid‐Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function

Xu Liao, Min Tang, Jiejing Li, Runze Guo, Chongbin Zhong, Xiangzhou Chen, Xuwei Zhang, Hongwei Mo, Dongdong Que, Wenjie Yu, Xudong Song, Hekai Li und 2 weitere

Advanced Healthcare Materials · 2025-03 · 14 (7)

DOI: 10.1002/adhm.202404319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 20.01.2025. Verfasst von Xu Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, P. R. China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Homeostasis, Oligopeptides, Mitochondria. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Science and Technology Program of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Redox imbalance, including excessive production of reactive oxygen species (ROS) caused by mitochondrial dysfunction and insufficient endogenous antioxidant capacity, is the primary cause of myocardial ischemia‒reperfusion (I/R) injury. In the exploration of reducing myocardial I/R injury, it is found that protecting myocardial mitochondrial function after reperfusion not only reduces ROS bursts but also inhibits cell apoptosis triggered by the release of cytochrome c. Additionally, nuclear factor erythroid 2‐related factor 2 (Nrf2) is considered a potential therapeutic target for treating myocardial I/R injury by enhancing the cellular antioxidant capacity through the induction of endogenous antioxidant enzymes. In this study, a peptide‒drug conjugate OI‐FFG‐ss‐SS31(ISP) is developed by integrating the Nrf2 activator 4‐octyl itaconate (OI) and the mitochondria‐targeting protective peptide elamipretide (SS31), and its therapeutic potential for myocardial I/R injury is explored. The results showed that ISP could self‐assemble into nanofibers in response to the acidic microenvironment and bind to Keap‐1 with high affinity, thereby activating Nrf2 and enhancing antioxidant capacity. Simultaneously, the release of SS31 could improve mitochondrial function and reduce ROS, ultimately providing a restoration of redox homeostasis to effectively alleviate myocardial I/R injury. This study presents a promising acid‐triggered peptide‐drug conjugate for treating myocardial I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryHomeostasisOligopeptidesMitochondriaPeptidesMitochondria, HeartAnimalsOxidation-ReductionNF-E2-Related Factor 2ApoptosisReactive Oxygen SpeciesMaleKelch-Like ECH-Associated Protein 1RatsMiceMyocytes, CardiacAntioxidantsRats, Sprague-Dawley

Stichwörter der Autor:innen

cardiac ischemia‒reperfusion injurymitochondrial functionpeptide–drug conjugatesredox homeostasisself‐assembled peptides

Substanzen

NF-E2-Related Factor 2arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamideOligopeptidesReactive Oxygen SpeciesKelch-Like ECH-Associated Protein 1AntioxidantsPeptides

Autor:innen und Institutionen

  • Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, P. R. China.
  • Heart Center of Zhujiang Hospital, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Guangzhou, 510280, P. R. China.
  • Department of Cardiology of Zhuzhou Central Hospital, NO.116 Changjiang South Road Tianyuan District, Zhuzhou, 412000, P. R. China.

ORCID-Profile: Pingzhen Yang

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Science and Technology Program of Guangzhou
  • Key R&D projects in Hainan Province
  • Natural Science Foundation of Hunan Province
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Liao, X., Tang, M., Li, J., Guo, R., Zhong, C., Chen, X., Zhang, X., Mo, H., Que, D., Yu, W., Song, X., Li, H., Cai, Y., & Yang, P. (2025). Acid‐Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function. Advanced Healthcare Materials, 14(7). https://doi.org/10.1002/adhm.202404319

Vancouver

Liao X, Tang M, Li J, Guo R, Zhong C, Chen X, et al. Acid‐Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function. Advanced Healthcare Materials. 2025;14(7). doi:10.1002/adhm.202404319

BibTeX
@article{Liao2025,
  author = {Liao, Xu and Tang, Min and Li, Jiejing and Guo, Runze and Zhong, Chongbin and Chen, Xiangzhou and Zhang, Xuwei and Mo, Hongwei and Que, Dongdong and Yu, Wenjie and Song, Xudong and Li, Hekai and Cai, Yanbin and Yang, Pingzhen},
  title = {Acid‐Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {7},
  doi = {10.1002/adhm.202404319}
}
Kostenlos starten →